๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A phase I trial of gemcitabine, docetaxel and carboplatin administered every 2

โœ Scribed by Vasiliki Bozionelou; Kostas Kalbakis; Lambros Vamvakas; Sofia Agelaki; Nikolaos Androulakis; Antonia Kalykaki; Vassilis Georgoulias; Dimitris Mavroudis

Publisher
Springer
Year
2009
Tongue
English
Weight
275 KB
Volume
64
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase I trial of weekly docetaxel and ge
Phase I trial of weekly docetaxel and gemcitabine in patients with refractory malignancies
โœ Tarek Mekhail; Thomas E. Hutson; Paul Elson; G. Thomas Budd; Gordon Srkalovic; T ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 97 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND A Phase I study using weekly docetaxel and gemcitabine was conducted to investigate toxicity; to determine the maximum tolerated dose (MTD) of each agent; and, in a preliminary fashion, to determine the antitumor activity of the combination. ## METHODS Docetaxel and gem